Make Way for CalIBR

Merck this week launched the California Institute for Biomedical Research, or CalIBR, "a new nonprofit research institute to help academics turn their basic biology insights into drug compounds ready for human tests," Science reports, adding that the pharmaceutical company is contributing $42 million over the first three years, and possibly as much as $90 million over the first seven years, to the institute.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.